CME Group Inc. (NASDAQ:CME) Stake Boosted by Los Angeles Capital Management LLC

Los Angeles Capital Management LLC lifted its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 39.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 204,238 shares of the financial services provider's stock after purchasing an additional 58,037 shares during the period. Los Angeles Capital Management LLC owned 0.06% of CME Group worth $45,065,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the business. Harbor Capital Advisors Inc. raised its position in shares of CME Group by 0.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider's stock worth $1,723,000 after acquiring an additional 45 shares in the last quarter. CVA Family Office LLC grew its position in shares of CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider's stock worth $96,000 after buying an additional 46 shares during the period. Lester Murray Antman dba SimplyRich increased its stake in shares of CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider's stock worth $1,507,000 after acquiring an additional 50 shares in the last quarter. Quent Capital LLC boosted its stake in CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider's stock worth $131,000 after acquiring an additional 55 shares in the last quarter. Finally, Grove Bank & Trust grew its holdings in CME Group by 1.3% in the third quarter. Grove Bank & Trust now owns 4,276 shares of the financial services provider's stock worth $943,000 after purchasing an additional 55 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the completion of the transaction, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the business's stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of the company's stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now owns 10,589 shares of the company's stock, valued at approximately $2,403,279.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock worth $3,441,063 in the last 90 days. 0.30% of the stock is owned by insiders.

CME Group Stock Up 1.6 %

Shares of CME stock traded up $3.62 during trading hours on Friday, reaching $225.66. 1,798,000 shares of the stock were exchanged, compared to its average volume of 1,483,283. The business's fifty day moving average is $221.72 and its two-hundred day moving average is $209.86. The firm has a market capitalization of $81.26 billion, a P/E ratio of 23.73, a P/E/G ratio of 5.56 and a beta of 0.55. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating analysts' consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business's revenue for the quarter was up 18.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.25 EPS. As a group, research analysts expect that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. CME Group's payout ratio is 48.37%.

Analyst Ratings Changes

A number of analysts have weighed in on CME shares. Oppenheimer raised their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an "outperform" rating in a research note on Thursday, October 24th. Redburn Atlantic downgraded CME Group from a "buy" rating to a "neutral" rating and set a $244.00 target price on the stock. in a research note on Tuesday, October 8th. TD Cowen initiated coverage on CME Group in a report on Thursday, September 26th. They issued a "hold" rating and a $221.00 target price for the company. Barclays increased their price objective on CME Group from $219.00 to $231.00 and gave the company an "equal weight" rating in a research report on Thursday, October 24th. Finally, The Goldman Sachs Group boosted their target price on CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a research report on Thursday, October 3rd. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.